Skip to main content

Articles

Page 32 of 38

  1. Epigenetic alterations, such as aberrant DNA methylation, are a hallmark of cancer. DNA hypermethylation of the promoter region affects, for example, the expression of tumor suppressor genes and is associated ...

    Authors: Oliver Zolk and Martin F Fromm
    Citation: Genome Medicine 2012 4:10
    Content type: Research highlight Published on:

  9. The R620W variant in protein tyrosine phosphatase non-receptor 22 (PTPN22) is associated with rheumatoid arthritis (RA). The PTPN22 gene has alternatively spliced transcripts and at least two of the splice forms ...

    Authors: Marcus Ronninger, Yongjing Guo, Klementy Shchetynsky, Andrew Hill, Mohsen Khademi, Tomas Olsson, Padmalatha S Reddy, Maria Seddighzadeh, James D Clark, Lih-Ling Lin, Margot O'Toole and Leonid Padyukov
    Citation: Genome Medicine 2012 4:2
    Content type: Research Published on:

  10. Several theories have been proposed to conceptualize the pathological processes inherent to schizophrenia. The 'prostaglandin deficiency' hypothesis postulates that defective enzyme systems converting essentia...

    Authors: Matej Orešič, Tuulikki Seppänen-Laakso, Daqiang Sun, Jing Tang, Sebastian Therman, Rachael Viehman, Ulla Mustonen, Theo G van Erp, Tuulia Hyötyläinen, Paul Thompson, Arthur W Toga, Matti O Huttunen, Jaana Suvisaari, Jaakko Kaprio, Jouko Lönnqvist and Tyrone D Cannon
    Citation: Genome Medicine 2012 4:1
    Content type: Research Published on:

  11. Targeted therapy with tyrosine kinase inhibitors has led to a substantial improvement in the standard of care for patients with advanced or metastatic clear cell renal cell carcinoma. Because the mechanism of ...

    Authors: Ram N Ganapathi and Ronald M Bukowski
    Citation: Genome Medicine 2011 3:79
    Content type: Research highlight Published on:

  14. Fragile X syndrome is the most common cause of inherited intellectual disability, but the underlying pathophysiology is complex and effective treatments are lacking. In a recent study of fragile X mental retardat...

    Authors: Inge Heulens, Sien Braat and R Frank Kooy
    Citation: Genome Medicine 2011 3:80
    Content type: Research highlight Published on:

  16. Organic cation transporters (OCTs) determine not only physiological processes but are also involved in the cellular uptake of anticancer agents. Based on microarray analyses in hepatocellular carcinoma (HCC), SLC...

    Authors: Elke Schaeffeler, Claus Hellerbrand, Anne T Nies, Stefan Winter, Stephan Kruck, Ute Hofmann, Heiko van der Kuip, Ulrich M Zanger, Hermann Koepsell and Matthias Schwab
    Citation: Genome Medicine 2011 3:82
    Content type: Research Published on:

  19. Glioblastoma multiforme (GBM) is the most common, aggressive and malignant primary tumor of the brain and is associated with one of the worst 5-year survival rates among all human cancers. Identification of mo...

    Authors: Rotem Ben-Hamo and Sol Efroni
    Citation: Genome Medicine 2011 3:77
    Content type: Research Published on:

    The Erratum to this article has been published in Genome Medicine 2012 4:87

  20. MicroRNAs are post-transcriptional regulators that are involved in many physiological and pathophysiological conditions. A recent study compared the expression profiles of hundreds of blood-borne microRNAs acr...

    Authors: Nathalie Schöler, Christian Langer and Florian Kuchenbauer
    Citation: Genome Medicine 2011 3:72
    Content type: Research highlight Published on:

  21. Initial high-throughput RNA sequencing (RNA-Seq) experiments have revealed a complex and dynamic transcriptome, but because it samples transcripts in proportion to their abundances, assessing the extent and na...

    Authors: Adam Roberts and Lior Pachter
    Citation: Genome Medicine 2011 3:74
    Content type: Research highlight Published on:

  22. A report on the Cold Spring Harbor Laboratory meeting on 'Personal Genomes', Cold Spring Harbor, New York, USA, 30 September to 2 October, 2011.

    Authors: Melissa Gymrek and Yaniv Erlich
    Citation: Genome Medicine 2011 3:73
    Content type: Meeting report Published on:

  23. A report on the Wellcome Trust Scientific Conference 'Epigenomics of Common Diseases', Hinxton, Cambridge, UK, September 13-16, 2011.

    Authors: Kate Revill and Benjamin Tycko
    Citation: Genome Medicine 2011 3:71
    Content type: Meeting report Published on:

  29. We present a new method to analyze cancer of unknown primary origin (CUP) samples. Our method achieves good results with classification accuracy (88% leave-one-out cross validation for primary tumors from 56 c...

    Authors: Kalle A Ojala, Sami K Kilpinen and Olli P Kallioniemi
    Citation: Genome Medicine 2011 3:63
    Content type: Method Published on:

  31. Pharmacogenetic testing holds major promise in allowing physicians to tailor therapy to patients based on genotype. However, there is little data on the impact of pharmacogenetic test results on patient and cl...

    Authors: Wendy Lorizio, Hope Rugo, Mary S Beattie, Simone Tchu, Teri Melese, Michelle Melisko, Alan HB Wu, H Jeffrey Lawrence, Michele Nikoloff and Elad Ziv
    Citation: Genome Medicine 2011 3:64
    Content type: Research Published on:

  34. Stem cells hold great promise for pancreatic beta cell replacement therapy for diabetes. In type 1 diabetes, beta cells are mostly destroyed, and in type 2 diabetes beta cell numbers are reduced by 40% to 60%....

    Authors: Gordon C Weir, Claudia Cavelti-Weder and Susan Bonner-Weir
    Citation: Genome Medicine 2011 3:61
    Content type: Review Published on:

  37. The hepatitis C virus (HCV) infects nearly 3% of the World's population, causing severe liver disease in many. Standard of care therapy is currently pegylated interferon alpha and ribavirin (PegIFN/R), which i...

    Authors: Katherine R Smith, Vijayaprakash Suppiah, Kate O'Connor, Thomas Berg, Martin Weltman, Maria Lorena Abate, Ulrich Spengler, Margaret Bassendine, Gail Matthews, William L Irving, Elizabeth Powell, Stephen Riordan, Golo Ahlenstiel, Graeme J Stewart, Melanie Bahlo, Jacob George…
    Citation: Genome Medicine 2011 3:57
    Content type: Research Published on:

  39. Hypoxia is a feature of most solid tumors and is associated with poor prognosis in several cancer types, including breast cancer. The master regulator of the hypoxic response is the Hypoxia-inducible factor 1α...

    Authors: Elena Favaro, Simon Lord, Adrian L Harris and Francesca M Buffa
    Citation: Genome Medicine 2011 3:55
    Content type: Review Published on:

  43. Q fever is a worldwide zoonosis caused by Coxiella burnetii. The disease most frequently manifests clinically as a self-limited febrile illness, as pneumonia (acute Q fever) or as a chronic illness that presents ...

    Authors: Malgorzata Kowalczewska, Zuzana Sekeyová and Didier Raoult
    Citation: Genome Medicine 2011 3:50
    Content type: Review Published on:

  44. Genetic risk models could potentially be useful in identifying high-risk groups for the prevention of complex diseases. We investigated the performance of this risk stratification strategy by examining epidemi...

    Authors: Raluca Mihaescu, Ramal Moonesinghe, Muin J Khoury and A Cecile JW Janssens
    Citation: Genome Medicine 2011 3:51
    Content type: Research Published on:

  47. Innovative 'systems' approaches to biomedical research offer substantial promise for advancing knowledge and improving health care, as outlined by Bousquet et al. in this issue. However, they are unlikely to impr...

    Authors: Wylie Burke and Susan Brown Trinidad
    Citation: Genome Medicine 2011 3:47
    Content type: Research highlight Published on:

  48. Data sharing is increasingly regarded as an ethical and scientific imperative that advances knowledge and thereby respects the contributions of the participants. Because of this and the ever-increasing amount ...

    Authors: Bartha Maria Knoppers, Jennifer R Harris, Anne Marie Tassé, Isabelle Budin-Ljøsne, Jane Kaye, Mylène Deschênes and Ma'n H Zawati
    Citation: Genome Medicine 2011 3:46
    Content type: Correspondence Published on:
Submit manuscript

Follow

Annual Journal Metrics

  • 2022 Citation Impact
    12.3 - 2-year Impact Factor
    13.8 - 5-year Impact Factor
    2.422 - SNIP (Source Normalized Impact per Paper)
    4.851 - SJR (SCImago Journal Rank)

    2023 Speed
    9 days submission to first editorial decision for all manuscripts (Median)
    185 days submission to accept (Median)

    2023 Usage 
    2,331,772 downloads
    4,916 Altmetric mentions

  • Peer Review Taxonomy

    This journal is participating in a pilot of NISO/STM's Working Group on Peer Review Taxonomy, to identify and standardize definitions and terminology in peer review practices in order to make the peer review process for articles and journals more transparent. Further information on the pilot is available here. 

    The following summary describes the peer review process for this journal:

    • Identity transparency: Single anonymized
    • Reviewer interacts with: Editor
    • Review information published: None

    We welcome your feedback on this Peer Review Taxonomy Pilot. Please can you take the time to complete this short survey.

Genome Medicine

ISSN: 1756-994X

Contact us